Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir [clinicaltrials:NCT00001133]
Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir [clinicaltrials:NCT00001133]
Bio2RDF identifier
NCT00001133
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00001133
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
In this study, the prot ...... f using IDV and RTV together.
brief title [clinicaltrials_vocabulary:brief-title]
Safety and Tolerance of Indina ...... vir, Nelfinavir, or Saquinavir
completion date [clinicaltrials_vocabulary:completion-date]
2006-08-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
IDV, a protease inhibit ...... ive pharmacokinetic analysis.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2000-01-17T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Anti-HIV Agents
Dose-Response Relationship, Drug
Drug Therapy, Combination
HIV Protease Inhibitors
Pharmacokinetics
Treatment Experienced
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2012-05-21T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00001133
official title [clinicaltrials_vocabulary:official-title]
A Phase I/II, Randomized, Open ...... Saquinavir Combination Therapy
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2012-05-01T00:00:00Z
identifier
clinicaltrials:NCT00001133
title
Safety and Tolerance of Indina ...... vir, Nelfinavir, or Saquinavir
@en
type
label
Safety and Tolerance of Indina ...... r [clinicaltrials:NCT00001133]
@en